Table 2.
Distribution of the first severe morbid event in untreated HIV-infected children
| Diagnosis | Number of first events, n(%) | Lethal events, n(%) | ||
|---|---|---|---|---|
| WHO Stage 2 | ||||
| Hepatosplenomegaly | 1 | (1,7) | - | |
| WHO Stage 3 | ||||
| Failure to thrive (FTT) | 2 | (3,6) | 1 | (50) |
| Unexplained persistent diarrhoea | 4 | (7,1) | - | |
| Unexplained persistent fever | 1 | (1,7) | - | |
| Tuberculosis | 1 | (1,7) | 1 | (100) |
| Chronic lung disease | 4 | (7,1) | - | |
| Severe bacterial infections | 4 | (7,1) | 2 | (50) |
| WHO Stage 4 | ||||
| Pneumonia | 1 | (1,7) | - | |
| Other diagnosis of interest | ||||
| Malaria | 21 | (37,5) | - | |
| Meningitis | 2 | (3,6) | 2 | (100) |
| Unknown | 15 | (26,7) | 10 | (67) |
| Total | 56 | (100) | 16 | (28,6) |
Children followed-up over 18 months by the CePReF and the MTCT-Plus programme, Abidjan, Côte d'Ivoire (January-2004-December 2009). n = 405.